跳至主要内容
临床试验/NCT06683534
NCT06683534尚未招募2 期

Use of Quercetin to Increase Resiliency to Palmitic Acid in the Human Microvasculature

Medical College of Wisconsin1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
入组人数
40
试验地点
1
主要终点
Change in blood vessel dilation

研究概览

简要总结

The goal of this study is to learn how a supplement Quercetin can affect microvascular function.

Participants will:

  • give two blood draws of 5 mL each
  • have a camera placed under the tongue to take pictures of blood vessels
  • have 2 laser Doppler microdialysis catheters placed on the forearm to monitor blood vessels before and after local drug infusion

Researchers will compare blood vessel function of those who take estrogen supplements to those who do not.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Obesity (BMI>30)
  • Aged 18-40 years
  • English Speaking

排除标准

  • Resting SBP ≥180 mmHg or DBP ≥ 110mmHg
  • Pregnancy or breastfeeding.
  • Prior history of myocardial infarction
  • Diagnosis of more than 1 risk factor for coronary artery disease (active smoker, diabetes mellitus- type 1 or 2, congestive heart failure, hyperlipidemia, hypertension)
  • Active mouth sores that affect the buccal mucosa.

研究组 & 干预措施

Use of oral quercetin to improve human microvascular function

Experimental

Quercetin is a non-FDA approved, over-the-counter supplement that has been shown to improve oxidative capacity in blood vessels.

干预措施: Quercetin (dietary supplement) (Dietary Supplement)

Placebo

Placebo Comparator

A placebo will be administered for 30 days followed by assessment of the subject's microvascular function.

干预措施: Placebo (Drug)

结局指标

主要结局

Change in blood vessel dilation

时间窗: 2 hours

Peripheral microvascular dilation in response to acetylcholine, L-NAME, and sodium nitroprusside infusions will be measured using laser Doppler flowmetry with microdialysis.

次要结局

  • Change in Perfused Vessel Density(0.5 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Julie K. Freed

Executive Vice Chair

Medical College of Wisconsin

研究点 (1)

Loading locations...

相似试验